9 Questions for Financial Planning Columnist Bob Veres
The future is bright. The present is awkward. Advisors need to transition to specialization and a better way to manage talent ...
Why We Upgraded JPMorgan Income ETF
JPMorgan Income ETF’s JPIE experienced, specialized, and collaborative team earned it a People Pillar rating boost to High, ...
News Highlights: Top Energy News of the Day - Friday at 7 AM ET
Oil futures gained on Thursday, with global benchmark prices turning higher for the week and buoyed by optimism over the outlook for demand. Southern California's Edison International owes its ...
Walgreens' stock jumps 7% after earnings sweep past estimates
Walgreens Boots Alliance Inc.'s stock (WBA) jumped 7% early Friday after the drugstore chain posted another loss but blew past estimates on an adjusted basis. The Deerfield, Illinois-based company had ...
Elevated Treasury yields are weighing on bitcoin. Here's a case for it dropping to $90,000.
The yield on the 10-year Treasury note BX:TMUBMUSD10Y had climbed for four consecutive days through Wednesday, before it dipped on Thursday, Dow Jones Market Data showed. The increase pushed the ...
Wall Street gets off to a bumpy start to 2025. How investors can prepare for more volatility ahead.
"Nobody can say when that period of volatility is going to occur in 2025. Investors should structure their portfolio so that they're able to remain invested throughout that period, and use them as ...
Jensen Huang crushed the quantum stocks, and now the so-called 'Pharma Bro' is going for the kill
Small quantum computing stocks dived this week after Nvidia (NVDA) CEO Jensen Huang made clear to investors what they should have already known. Talking to analysts at the CES convention in Las Vegas ...
Delta Air is betting on a strong 2025 driven by demand for premium travel
Delta Air Lines Inc.'s stock jumped 3.4% in premarket trade Friday, after the carrier beat fourth-quarter profit and revenue estimates and forecast a strong 2025 driven by demand for premium travel.
Mersana Shares Rise on Advances With Breast-Cancer Treatment
Mersana on Friday said the new designation covers the drug, XMT-1660, for the treatment of advanced or metastatic breast cancer in patients with human epidermal growth factor receptor 2 low or ...
Delta Air's stock jumps 3.4% after earnings beat as airline forecasts strong 2025 driven by premium travel
Delta Air Lines Inc.'s stock (DAL) jumped 3.4% in premarket trade Friday, after the carrier beat profit and revenue estimates and forecast a strong 2025 driven by demand for premium travel. The ...
Why Elon Musk had to drop his 'DOGE' pledge to cut $2 trillion from the federal budget
Two months ago here at MarketWatch, we told you that Elon Musk was talking out of his MAGA hat when he promised to cut "at least $2 trillion" from the $6.75 trillion federal budget. Now Musk has ...
Are Roth IRAs really better? Not necessarily.
But new research questions whether Roths really are better. Most taxpayers will be better off with a traditional IRA or 401 (k), argue finance professors Julia Camp, Stephen Kuselias and Sydnee Manley ...